|
|||||
|
|
Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens |
|
| Authors: | Robert A Smith Dana N Raugi Charlotte Pan Matthew Coyne Alexandra Hernandez Brad Church Kara Parker James I Mullins Papa Salif Sow Geoffrey S Gottlieb for the University of Washington–Dakar HIV- Study Group |
| Abstract: | |
| Keywords: | |